Is OPK a good buy

**OPKO Health (OPK)** appears to be a good buy based on the following points:

1. **Strong Analyst Confidence**: The consensus rating is Strong Buy, with an average price target of $2.75, which is significantly higher than the current trading price. This suggests that analysts are optimistic about the stock's future performance.
2. **Upward Momentum**: The stock's 5-Day, 10-Day, and 20-Day moving averages are 1.64, 1.62, and 1.54, respectively, indicating upward momentum. The Moving Average Convergence Divergence (MACD) is at 0.01, and the KDJ is at 55.97, suggesting that the stock is in an uptrend.

3. **Support Level**: The stock has a support level at $1.66, which could be a point of interest if the price were to approach it. The stock is trading above this support level, which could indicate a bullish trend.

4. **Financial Forecast**: The company's financial forecast for the next 12 months shows an average price target of $2.75, with a high forecast of $3.00 and a low forecast of $2.25. This suggests that analysts see potential for growth from the current price.
5. **Recent Developments**: The company has entered into a $250 million non-dilutive note purchase agreement, which could provide additional funding for growth. Additionally, the company has announced business highlights and financial results, which could contribute to investor confidence.

In conclusion, OPK's strong analyst consensus, upward momentum, and support level, combined with the company's recent developments, suggest that it may be a good buy for investors who are willing to take on the risks associated with the stock's current price and market conditions.